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schemata of molecular mechanisms of disease, would be welcome
– perhaps in the next edition. 
One of us had reviewed the first edition of Diseases of the
Breast in 1996 and was very impressed – the second edition is as
impressive and the content is thoroughly updated. It can therefore
be repeated that ‘this book deserves a place on the desk of anyone
interested in the subject’. 
Jayant S Vaidya, Mohammed Keshtgar and Michael Baum 
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This is the second edition of this large textbook, which first
appeared in 1995. It is one of several books that aim to give a
comprehensive account of the science, clinical features and
management of cancer. 
The growth of electronic libraries and reference systems in the
1990s worried medical publishers, particularly with respect to books
like this. Would clinicians continue to use them? It turns out that
they do. The reasons are obvious. It’s much easier to look something
up quickly in a book than to turn on your computer and struggle
through complex sorting procedures to find information that you
then have to read on a screen. Books are easy to browse, to dip into,
to find something quickly, to read on a train (although at 4.5 kg you
wouldn’t want this one to fall out of an overhead luggage rack). A
good book, writen to educate rather than to review current knowl-
edge, has a different purpose from a collection of reviews. This 
one is aimed at trainee and practising oncologists, as well as non-
specialists. It is a work of instruction and reference with a wide
audience. For the editors and publishers this means achieving
consistency of style and content. They have succeeded admirably. 
To start with the basics. It is 3000 pages long has 223 contribu-
tors, nearly all of whom are from North America. It is nicely
printed on paper with little see-through and with figures, tables
and colour prints that are, in the main, well thought out and with a
certain consistency and logic from chapter to chapter. The general
layout is conventional. It starts with the scientific underpinnings of
cancer medicine, moves on to the general principles of manage-
ment. It correctly places supportive care early in the book rather
than after the sections on specific cancers that follow. 
I always find the science parts of these books less useful than
the clinical. They are usually mini-reviews and often do not deal
conceptually with the subject at a level which will really engage
the reader. The authors, basic scientists of high repute, often show
little understanding of what the reader will wish to know, or where
he or she might have difficulty in understanding. If the function of
these sections is to teach and to explain, the text must concern
itself with the clear exposition of principles. In this book many of
the contributions are first-rate from this point of view. These chap-
ters have good diagrams to explain difficult ideas. It’s curious,
though, that there is cumulatively much more space devoted to the
science of potential biological treatments – most of which are of
uncertain value – than there is to the scientific basis of drug treat-
ment – which often works. As usual there are hundreds of refer-
ences in these and the other chapters. These have become an
obsession in medical writing. It seems that you can’t write that
patients are anxious about the diagnosis of cancer without giving
three references. Who uses these lists? Why don’t we limit
ourselves, in textbooks of medical education and practice, to refer-
ences to really good reviews or essential original articles? 
The sections on the general aspects of cancer management –
metastases, effusions, cord compression, paraneoplastic syn-
dromes, nausea, cachexia, fever – are excellent. Here, as elsewhere
in the book, there are summary boxes and algorithms which will
help the physician, especially the trainee. The advice on diagnosis
and management is clear and written concisely. I found myself
occasionally at odds with some of the recommendations. Mostly
this was when advice was being given about treatment, in situa-
tions where there is no chance of cure, without the option of not
treating being considered. This remark will doubtless be seen as a
typical example of UK nihilism and attributed to our health care
system. It isn’t. It’s good practice not to give active treatment
sometimes. 
How does a reviewer give a fair account of the remaining 2000
pages of the specific tumours? I had this book for 6 months before
writing this review – to the immense frustration of the Editor of the
Journal. The reason was that I used it to look things up when I
wasn’t sure of my facts. It’s a good test of whether a book actually
works I think. It seldom let me down. I found it easy to find my way
around. I read the sections on lung cancer, lymphoma, bone and
soft-tissue sarcoma and childhood cancer thoroughly, and indi-
vidual problems in many of the other sections. I found the descrip-
tion of the clinical features to be very good, the advice about
diagnosis and staging to be sensible and straightforward, and the
approach to management to be up-to-date and clear. There is a
tendency for chemotherapy to be given a greater weight in some
cancers than the results actually justify, but this probably reflects a
feature of North American practice. There was one area of real
confusion and that is in the discussion of round cell sarcomas of
bone. This has found its way into two chapters, neither of which
deals with the management well. 
The graphic illustration is clear, the clinical algorithms are
useful. The tables of chemotherapy regimens are highly selected
(they always are) and reflect the authors’ own preoccupations, but
those that I looked at in detail seemed to me to be a fair summary
of the most useful modern regimens. 
In summary, this is a first-rate book. I congratulate the Editors. I
know what a task it must have been to ensure consistency of style
and content and to achieve a balance between the chapters. It will
be in every oncologist’s library. In my view it is one of the best big
books on cancer. 
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